Patents Assigned to The University of Biritish Columbia
  • Publication number: 20130336962
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R, R1, R2, R3, R4, M1, M2, X, L1, L2, J1, J2, a1, a2, b1 and b2 are as defined herein, and wherein at least one of M2 or L2 is a moiety comprising an aziridine, acrylamide or sulfonate functional group, are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.
    Type: Application
    Filed: April 16, 2013
    Publication date: December 19, 2013
    Applicants: The University of Biritish Columbia, British Columbia Cancer Agency Branch
    Inventors: British Columbia Cancer Agency Branch, The University of British Columbia